NYSE:DHR
NYSE:DHRLife Sciences

Assessing Danaher’s Prospects After a 22% Drop and Outlook for 2025

If you have Danaher on your watchlist, you are not alone in wondering whether now is the right moment to act. The past year has been a wild ride for the stock, dragging it down by 22.3% over twelve months and by 9.6% year-to-date. Even with a modest uptick of 1.1% in the last month, Danaher still has not fully shaken concerns about shifting market sentiment and broader volatility in health sciences and industrial technology sectors. Looking further back, the five-year return of 14.8% serves...
NYSE:T
NYSE:TTelecom

Assessing AT&T’s Value After Shares Surge 53% and Analysts Highlight Policy Tailwinds

If you have been eyeing AT&T and wondering whether now is the right time to make a move, you are not alone. The market has been watching closely as this telecom giant’s stock steadily climbed, with AT&T delivering a 53.1% gain over the past year and 25.9% just since the start of this year. Even after a minor dip of -0.8% in the past week, the long-term chart hints at real staying power, topped off by a 92.2% three-year return. That kind of outperformance inevitably sparks debates about...
NYSEAM:UEC
NYSEAM:UECOil and Gas

Is There Still Opportunity in Uranium Energy After 96% Share Price Surge?

If you are wondering whether Uranium Energy deserves a spot in your portfolio, you are not alone. With uranium prices grabbing global headlines and investors seeking exposure to clean energy sources, Uranium Energy’s stock has caught quite a few eyes. Over the last year alone, shares have skyrocketed by a staggering 96.2%. Even when you zoom out to the last five years, the stock has climbed an incredible 804.3%, handily outperforming many peers. Of course, no stock moves in a straight line...
NYSE:QXO
NYSE:QXOTrade Distributors

QXO’s Surging Sales and Sector Moves Could Be a Game Changer For QXO (QXO)

In August 2025, Benchmark initiated coverage of QXO, Inc., highlighting the company’s expansion plans and its recent acquisition of Beacon Roofing, while analysts emphasized upcoming executive appointments and sector consolidation trends. An interesting insight is that QXO’s significant rise in reported sales, from US$14.5 million last year to US$1.91 billion this quarter, coincides with increasing analyst optimism about its broader growth opportunities beyond its initial acquisition. We’ll...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Did Strong Q2 Results and New Partnerships Just Shift Workday's (WDAY) Investment Narrative?

Workday reported its second-quarter 2025 earnings, showing revenue of US$2.35 billion and net income of US$228 million, both up from a year ago, while also raising its full-year subscription revenue guidance following strong first-half momentum and recent acquisitions. In addition, new partnerships with Chime and DailyPay are expanding Workday's reach in financial wellness and on-demand pay services, underscoring a broader move toward integrated, AI-powered employee benefits within its HR...
BATS:CBOE
BATS:CBOECapital Markets

Is a Bigger Dividend and New Strategy Chief Signaling a Shift in Cboe’s Growth Playbook (CBOE)?

Cboe Global Markets recently announced a 14% increase in its quarterly dividend and named Prashant Bhatia as Executive Vice President, Head of Enterprise Strategy & Corporate Development, effective September 2, 2025. Bhatia brings more than 30 years of global financial services experience and a strong track record in corporate development, signaling increased emphasis on long-term growth initiatives. We'll examine how the substantial dividend hike signals management's confidence in Cboe's...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

How Does Amgen Stack Up After Humira Biosimilar Launch and Recent Price Swings?

Thinking about what to do with Amgen stock lately? You are not alone. With biotech making headlines and market sentiment shifting, a lot of investors are weighing their next move. Looking over the past year, Amgen has seen some ups and downs: the stock is down 1.4% this week, off 5.9% for the month, but still up a healthy 11.3% since January. If you zoom out even farther, its 3- and 5-year performances show gains of 32.6% and 33.2%, respectively, although it is off by 8.8% compared to this...
NYSE:KVUE
NYSE:KVUEPersonal Products

Does the Recent Kenvue Stock Dip Signal Opportunity for 2025 Investors?

If you are wondering what to do with Kenvue stock after its recent trading swings, you are not alone. Many investors are weighing whether the dip in price is an opportunity, a warning, or just another chapter in this company’s story. Kenvue’s shares recently closed at $21.19, down 1.4% over the past week and 7.2% across the last 30 days, while staying nearly flat for the year so far. The stock’s modest 0.3% gain over the past year hints at resilience, but also raises eyebrows for those...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

Did S&P 500 Inclusion Just Transform Interactive Brokers Group’s (IBKR) Investment Trajectory?

On August 28, 2025, Interactive Brokers Group is set to join the S&P 500 index, replacing Walgreens Boots Alliance as announced by S&P Dow Jones Indices. This addition follows recent product releases, including the "Connections" investment discovery tool and the rollout of commission-free US stock trading in Singapore, highlighting Interactive Brokers' ongoing global and platform innovation efforts. We'll examine how S&P 500 inclusion may strengthen Interactive Brokers’ investment narrative,...
NasdaqGS:PINC
NasdaqGS:PINCHealthcare

Can Premier’s (PINC) Acquisition Strategy Offset Softer Results and Cautious Outlook?

Premier, Inc. recently reported its fourth quarter and full-year 2025 earnings, revealing lower revenues of US$262.86 million for the quarter and US$1.01 billion for the year, alongside reduced net income and earnings per share compared to the previous year. Alongside weaker results and cautious 2026 revenue guidance, Premier highlighted ongoing share repurchases, a steady dividend, and new plans to pursue tuck-in acquisitions to strengthen its core offerings. We'll explore how Premier's...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Can Rising Losses at Pharvaris (PHVS) Reveal Deeper Challenges in Its Path to Profitability?

On August 12, 2025, Pharvaris N.V. reported its second quarter and six-month financial results, revealing a net loss of €45.48 million and €91.82 million, respectively, both higher than the same periods last year. The company’s losses per share from continuing operations also increased significantly year-over-year, indicating ongoing financial pressures. With widening losses driving recent earnings headlines, we’ll explore how this shapes Pharvaris’s investment narrative amid persistent cost...
NYSE:HUBS
NYSE:HUBSSoftware

What Recent Volatility and Growth Forecasts Mean for HubSpot Stock in 2025

If you are wondering what to do with HubSpot stock right now, you are in good company. Investors have been on a wild ride lately, with the stock climbing 4.4% over the past week, yet still sitting nearly 33% lower year-to-date. That kind of volatility can stir up lots of questions, especially when you realize that just in the last five years, HubSpot has delivered returns over 56%. Clearly, the story here is more complex than a single quarter or market shift. Part of that story comes down to...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Is Constellation Energy Still a Standout After Recent Stock Dip and Impressive Yearly Gains?

Thinking about what to do with Constellation Energy stock? You are not alone. With so much movement in the market, it can be tough to know when to sit tight and when to take action. Lately, Constellation Energy has given investors a lot to talk about. Over the last week, the stock dipped 3.7%, and in the past month, it slid by 5.1%. If you zoom out, the story becomes more interesting. Shares are still up a notable 28.1% year-to-date, and an impressive 60.4% over the past 12 months. Looking...
NYSE:STZ
NYSE:STZBeverage

Is Constellation Brands Set for a Rebound After Canada Cuts US Alcohol Imports?

Certainly! Here is your revised article text with em dashes removed and replaced with clearer formatting: If you have been watching Constellation Brands lately and wondering if it is time to buy, hold, or steer clear, you are not alone. The stock just closed at $163.68, but its journey here has been anything but smooth. Stepping back, the numbers paint a sobering picture: the stock is down 1.3% over the last week, has slid 6.7% in the past month, and has dropped a hefty 26.5% year-to-date...
NYSE:CACI
NYSE:CACIProfessional Services

Does CACI’s $1.8 Billion in New Contracts Enhance Its Long-Term Growth Story (CACI)?

Earlier this month, CACI International announced it was awarded two contracts with the Canadian Armed Forces for a US$124 million, 10-year counter-drone vehicle program, and a US$1.64 billion indefinite-delivery technical support contract with the U.S. Transportation Command. These multi-year government contracts underscore the company's expanding presence as a provider of advanced defense technology solutions in North America. We'll examine how these new contracts could strengthen CACI...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Is Biogen’s Recent Eisai Partnership a Turning Point for Its 2025 Stock Valuation?

Thinking about what to do with Biogen stock right now? You are not alone. There's a lot of debate swirling around this biotech giant, especially as its shares have been through quite the journey over the past few years. Some investors have been disappointed by the slide—down over 33.4% in the past year and more than 50% in the last five years—while others are starting to pay attention to signs that sentiment could be shifting. Over the last week, Biogen stock crept up a modest 0.3%, with a...
NYSE:MTDR
NYSE:MTDROil and Gas

Matador Resources (MTDR) Is Up 7.4% After Record Q2 Production and Strong Balance Sheet Update

Matador Resources recently reported record quarterly production for fiscal Q2 2025 and highlighted its strong balance sheet, with over US$1.8 billion in liquidity and a leverage ratio below 1.0x as of June 30. This financial and operational update underscores the company’s ongoing focus on production growth and fiscal discipline amid evolving industry conditions. We’ll explore how Matador’s record production performance in Q2 2025 could influence its future investment narrative and strategic...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Is Webull’s Recent 6% Decline a Sign to Revisit Its 2025 Valuation?

If you have been following Webull lately, you probably noticed the buzz in the investment community. Many investors are watching closely, trying to decide whether to double down or take profits now that the stock has had such a dynamic ride. Webull's story is hard to ignore. After climbing an impressive 28.7% since the start of the year and delivering a strong 33.3% gain over the past twelve months, expectations are running high. Despite those impressive long-term returns, the last month has...
NYSE:TJX
NYSE:TJXSpecialty Retail

How the Latest TJX Companies Earnings Beat Impacts Its Current Valuation in 2025

If you are looking at TJX Companies and wondering if now is the right moment to buy, hold, or rethink your position, you are not alone. The stock has been quietly rewarding patient shareholders for years, with the last five years bringing a powerful 165.6% return and an impressive 124.1% jump over three years. Even in the past month, TJX has gained 7.2%, and year-to-date it is up 11.8%. Despite some ongoing changes in consumer behavior and broader market developments, investor sentiment for...
NYSE:RCL
NYSE:RCLHospitality

Is Royal Caribbean Still a Good Value After Its 106% Jump in 2024?

If you are weighing what to do about Royal Caribbean Cruises stock right now, you are not alone. The share price has been a livewire, delivering a 106.3% jump over the past year and a remarkable 735.6% over the last three years, making those pandemic-era lows seem like ancient history. Even in the short term, Royal Caribbean is still riding some waves, up 4.5% in the last week but down 2.2% over the past month, as investors digest changing market sentiment and industry headlines. Momentum...